Express Pharma

FEBRUARY 18, 2025

Zygel is expected to launch in Germany in 2028, whereas zatolmilast is not anticipated to launch in Germany during the forecast period. These therapies are set to represent the first treatments to be indicated for FXS.

Labelling 99

Labelling 99

Commonwealth Pharmacists Association

JUNE 30, 2025

Working alongside our valued member organisations, our goal is to reach over 10,000 pharmacists a year by 2028. But our goals for the Academy go beyond numbers; the Academy is about genuine stories of transformation. The early-career practitioner in Ghana, using data and design tools to reshape antimicrobial use in their community.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes 52

Express Pharma

DECEMBER 9, 2024

The scheme provides financial incentives for the manufacturing of notified products. PLI Scheme for Pharmaceuticals, with a financial outlay of Rs.

Immunization 102

Immunization Immunity 102

Fuld & Company Blog

NOVEMBER 11, 2024

This 20-year power purchase agreement aims to supply approximately 835 MW of carbon-free electricity, expected to support Microsoft’s data centers across the PJM Interconnection region by 2028. The revival of Three Mile Island is a noteworthy step in integrating existing nuclear infrastructure with modern technology demands 5.

52

52

European Pharmaceutical Review

APRIL 10, 2025

In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. The PFAS regulatory challenge As a result, in the EU, a joint PFAS Restriction Proposal under REACH was submitted in 2023, aiming for a full ban on all PFAS by 2028/2030. There is worldwide concern around the use of PFAS.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Documentation Communication 59

Express Pharma

JANUARY 17, 2025

By 2028, Lonza aims to ensure that 90 per cent of its spending comes from suppliers with sustainability scores and 67 per cent of Lonzas Scope 3 emissions are covered by suppliers with science-based targets, in alignment with Lonzas validated Scope 3 targets by the Science-Based Targets initiative (SBTi).

Dosage 104

Dosage Pharmaceutical Manufacturing Packaging Drug Development 104

Express Pharma

JUNE 25, 2025

The companies confirmed a phased reduction in the vaccine’s price to below USD 5 by 2028. The full transition of manufacturing from GSK to Bharat Biotech is expected to be complete by 2028. The price reduction is enabled through increased production capacity, cost-effective manufacturing processes, and low-margin pricing strategies.

Vaccines 66

Vaccines 66

European Pharmaceutical Review

JUNE 3, 2025

billion upfront and $2 billion total in non-contingent anniversary payments through 2028. BioNTech SEandBristol Myers Squibb ( BMS )have agreed a collaboration to advance a bispecific antibody, setting the stage for a potential new standard of care in cancer. BMS will pay BioNTech $1.5 billion in additional milestones.

52

52

Express Pharma

DECEMBER 20, 2024

With global spending on therapeutics in areas such as immunology and oncology expected to rise by 38 per cent through 2028, Indias real estate developers must align their offerings to support the sectors ambitions. Sustainability has emerged as a cornerstone of the growth narrative.

Biosimilars 103

Biosimilars Vaccines 103

Express Pharma

DECEMBER 20, 2024

GlobalData expects tavapadon to enter the market in 2028, and despite its impressive efficacy data, the drugs success will likely be influenced by its safety profile.

105

105

Express Pharma

JUNE 30, 2025

Policies such as the Life Sciences Policy 2023–2028, coupled with infrastructure investments like Genome Valley and Hyderabad Pharma City, have cultivated ground for growth and research. This prominence isn’t accidental. It’s the outcome of a long-term strategy spearheaded by government policies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Pharmaceutical Manufacturing 52

Express Pharma

APRIL 10, 2025

billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16 Needle-free injection technology is steadily gaining traction in the traditional injection market. The global market for needle-free injectors is estimated to be valued at $27.65

Vaccines 82

Vaccines Hospitals Packaging Dosage 82

Pharmaceutical Technology

JULY 10, 2025

Keytruda, which brought in $30bn in revenue in 2024, is approaching patent expirations set in 2028, and Merck is therefore intensifying efforts to restructure its portfolio, according to a report by Reuters. This agreement will enable the strong launch trajectory of this important medicine and provides value to Verona Pharma shareholders.”

Packaging 52

Packaging Hospitals Communication Drug Pricing 52

Pharmacy Times

JUNE 9, 2025

The findings were presented at the 2025 American Society of Clinical Oncology Annual Meeting, which was held in Chicago, Illinois.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 29

Pharmaceutical Technology

JUNE 25, 2025

The first tranche will be received by Revolution, following US Food and Drug Administration (FDA) approval of daraxonrasib to treat metastatic PDAC by January 2028. The debt facility portion consists of three tranches totalling up to $750m linked directly to daraxonrasib’s commercial milestones. Sign up for our daily news round-up!

Packaging 52

Packaging Communication Hospitals Drug Development 52

BioPharma Dive

JUNE 26, 2025

But Jakafi’s main patents expire in 2028, a date that for years now has been on investors’ radar as they’ve pressed Incyte on what it expects will take the drug’s place. The company has had a good deal of success with Jakafi, a multipurpose drug approved to treat rare blood cancers and graft-versus-host disease. billion in sales.

Drug Pricing 46

Drug Pricing Drug Development Vaccines 46

STAT

JULY 9, 2025

 Buying Verona will help Merck replace revenue it expects to lose when Keytruda, the cancer immunotherapy drug that generates $30 billion per year in sales, loses patent protection starting in 2028. billion in 2021. Merck

Pharmaceutical Companies 161

Pharmaceutical Companies Pharmaceutical Companies 161

STAT

NOVEMBER 14, 2024

The cancer immunotherapy Keytruda, which is Merck’s most important product and the best-selling drug in the world with $23 billion in annual sales, is set to lose patent protection and face competition from generic drugmakers as early as 2028.

252

252

The Pharmacist

JUNE 11, 2025

NHS funding to is to rise by 3% a year until 2028/29, the chancellor has announced today in her spending review. The government is providing a £29bn increase (£53bn cash increase) in annual NHS day-to-day spending from 2023/24 to 2028/29.

40

40

Pharmaceutical Technology

JUNE 10, 2025

Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

Beckers Hospital Review

JULY 2, 2025

The ambulatory care complex is slated to open as early as 2028. In February, Sutter unveiled plans for a $1 billion expansion aimed at enhancing care access in this region, including a flagship campus in Emeryville, featuring a new 335,000-square-foot medical center and ambulatory care complex.

Hospitals 71

Hospitals 71

Beckers Hospital Review

JULY 11, 2025

” Construction on the hospital and cancer center is expected to kick off in 2026, with projected openings in 2028. . “We planted our flag early, confident in the community’s potential and committed to being part of its future.”

Hospitals 52

Hospitals 52

STAT

NOVEMBER 19, 2024

patent expires in 2028. For Merck, the new under-the-skin, or subcutaneous, formulation of Keytruda could represent a major way of holding on to a larger share of Keytruda’s $25 billion in annual sales than would otherwise occur when the medicine’s U.S. It is the best-selling medicine in the world.

Immunization 333

Immunization Immunity 333

STAT

JUNE 2, 2025

BMS will also pay BioNTech up to $2 billion in annual payments through 2028. Bristol will pay $1.5 billion up front to BioNTech for a 50% share in the profits and losses from BNT327. BioNTech will then be eligible to receive up to $7.6 billion in additional development, regulatory, and commercial milestone payments.

Drug Development 251

Drug Development 251

European Pharmaceutical Review

MARCH 25, 2025

MSD intends to commit a further $8 billion of US capital investment by 2028, the firm shared. The company highlighted that it plans to increase its manufacturing and R&D capabilities and recruitment in the US. The post MSD to advance investigational Lp(a) inhibitor in nearly $2b deal appeared first on European Pharmaceutical Review.

Research Laboratories 52

Research Laboratories Vaccines 52

European Pharmaceutical Review

MARCH 12, 2025

MSD shared that a further $8 billion of US capital investment is anticipated by 2028. The intention is to widen its manufacturing and R&D capabilities and boost recruitment in the US.

Research Laboratories 52

Research Laboratories Vaccines Drug Development 52

Express Pharma

JUNE 5, 2025

By the year 2028, it is anticipated that all electricity consumers, encompassing small businesses and residential households, will possess the ability to choose their energy provider. However, post-2028, significant developments are expected, including: Green energy retailers offering exclusively 100 per cent renewable electricity.

78

78

Beckers Hospital Review

JULY 1, 2025

which is slated to open in early 2028. The building, now named Chippewa Valley Cooperative Hospital, will serve as an interim campus while the organization constructs a permanent state-of-the-art hospital in Lake Hallie, Wis., Louis-based Ascension acquired full ownership of Cedar Park (Texas) Medical Center for $436 million in cash.

Hospitals 59

Hospitals 59

European Pharmaceutical Review

OCTOBER 10, 2024

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). The overarching theme of our updated strategy to 2028 is that of change – rapid, somewhat unpredictable but nonetheless full of promise.

98

98

European Pharmaceutical Review

OCTOBER 24, 2023

billion in 2028, according to a report by Arizton. percent up to 2028. percent between the forecast period: 2023 and 2028. percent between the forecast period 2023-2028. Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 Having been valued at $27.04 percent in 2022.

Packaging 118

Packaging Labelling Compounding Pharmaceutical Companies 118

STAT

AUGUST 13, 2024

In a press release, the company said that the cuts would help it extend its cash reserves from the second half of 2026 into 2028. The Bay Area biotech brought in $32 million during the quarter but also reported a net loss of $1.6 Continue to STAT+ to read the full story…

358

358

Express Pharma

DECEMBER 13, 2024

billion by 2028, driven by data and content management, according to GlobalData. According to GlobalDatas latest report, Market and Opportunity Forecast to 2028, Data and Analytics 2024, the total global data and analytics market is forecast to increase at a compound annual growth rate (CAGR) of 9.5 per cent in 2028.

Compounding 105

Compounding 105

European Pharmaceutical Review

SEPTEMBER 6, 2023

million by 2028, with a CAGR of 7.3 percent from 2023 to 2028. Between 2023 to 2028, the research suggested that a greater focus on drug development, growing requirement for spectroscopy via cloud-based platforms, alongside the industry’s need for precise and effective analytical methods, will drive the market.

Drug Development 98

Drug Development 98

Beckers Hospital Review

JULY 11, 2025

Casey Batten , MD, was appointed chief medical officer of the 2028 Summer Olympic and Paralympic Games by Los Angeles-based Cedars-Sinai. Joe Perry was appointed CFO of AdventHealth Littleton (Colo.). Doug Shirley was appointed CFO of Louisville, Ky.-based based ScionHealth. Hannah McRae , CFO of Cody (Wyo.)

Hospitals 52

Hospitals Communication Mayo Clinic Department of Veterans Affairs 52

STAT

MAY 14, 2024

Last December, the agency determined the confirmatory trial was not acceptable and asked the company to run yet another trial, which must be completed by February 2028.

Dosage 349

Dosage 349

STAT

MARCH 25, 2024

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood. Now, Vertex may be on the move again. Continue to STAT+ to read the full story…

Drug Development 276

Drug Development 276

pharmaphorum

JUNE 8, 2023

Standalone Sandoz eyes $3bn in new product sales by 2028 Phil.Taylor Thu, 08/06/2023 - 07:57 Bookmark this

96

96